News

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

By Nicholas Bakalar, New York Times | 07.04.2011
Poverty is often cited as contributing to poor health. Now, in an unusual approach, researchers have calculated how many people...
By Sarah Boseley, The Guardian (UK) | 07.04.2011
High doses of drugs used to stimulate the ovaries of older women undergoing fertility treatment may be causing chromosomal abnormalities...
By Gina Maranto, Biopolitical Times guest contributor, Biopolitical Times | 07.02.2011

Since the birth of Louise Brown in 1978, the mainstream English-language press around the world has valorized IVF doctors and...

By Luke Timmerman, Xconomy | 06.30.2011
When Minnesota Democrat Al Franken and Massachusetts Republican Scott Brown line up on the same side of an issue, my...
By Huffington Post, Huffington Post | 06.24.2011

What ever happened to parents-to-be saying, "We don't care whether it's a boy or a girl, as long as it's...

By Regina Wang, Newsobserver.com | 06.23.2011
RALEIGH -- For more than 40 years, Charles Holt swallowed the shame and anger of being sterilized by the state...
By Robert Weisman, Boston Globe | 06.22.2011
Biotechnology industry leaders want to speed up the process of bringing drugs to market by broadening the mission of the...
By Keith Darce, Sign On San Diego | 06.22.2011
A divided oversight committee of California’s $3 billion stem cell research institute selected Los Angeles investment banker and attorney Jonathan...